Skip to Content
Merck
  • Nectin expression in pancreatic adenocarcinoma: nectin-3 is associated with a poor prognosis.

Nectin expression in pancreatic adenocarcinoma: nectin-3 is associated with a poor prognosis.

Surgery today (2015-02-19)
Hideki Izumi, Kenichi Hirabayashi, Naoya Nakamura, Toshio Nakagohri
ABSTRACT

Nectins are cell adhesion molecules that regulate the formation of adherens junctions and are linked with E-cadherin-based cell-cell adherens junctions. In pancreatic cancer, the expression of E-cadherin and nectins is considered to be related to metastasis, invasion and prognosis. We evaluated the distribution of cells that were positive for nectin subtypes and E-cadherin using immunohistochemistry in specimens of human pancreatic adenocarcinoma, and correlated these results with the clinicopathological features and patient outcomes. The immunohistochemical distribution of nectin-1 and E-cadherin showed a good correlation (r = 0.523, p < 0.01). Tumors over 4 cm in diameter had more intense staining for nectin-4 than smaller tumors (p = 0.035). Nectin-2 expression correlated with a poorer histological grade (p = 0.04). The cases that showed diffuse nectin-3 expression had a better prognosis than those with negative expression (p = 0.018). Our results showed that the expression of nectin-3 in pancreatic cancer can be a prognostic factor.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-NECTIN4 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution